Investors Asset Management of Georgia’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.35M | Buy |
18,616
+3
| +0% | +$395 | 0.82% | 34 |
|
|
2026
Q1 | $2.59M | Buy |
18,613
+483
| +3% | +$67.6K | 1.06% | 20 |
|
|
2025
Q4 | $2.23M | Buy |
18,130
+3
| +0% | +$365 | 0.92% | 29 |
|
|
2025
Q3 | $2.01M | Buy |
18,127
+3
| +0% | +$341 | 0.86% | 33 |
|
|
2025
Q2 | $2.01M | Buy |
18,124
+3
| +0% | +$319 | 0.93% | 30 |
|
|
2025
Q1 | $2.03M | Sell |
18,121
-346
| -2% | -$35.7K | 1.03% | 25 |
|
|
2024
Q4 | $1.71M | Buy |
18,467
+3
| +0% | +$270 | 0.83% | 35 |
|
|
2024
Q3 | $1.55M | Sell |
18,464
-96
| -0.5% | -$7.33K | 0.73% | 39 |
|
|
2024
Q2 | $1.27M | Sell |
18,560
-571
| -3% | -$38.1K | 0.62% | 50 |
|
|
2024
Q1 | $1.4M | Buy |
19,131
+284
| +2% | +$21.8K | 0.66% | 49 |
|
|
2023
Q4 | $1.53M | Sell |
18,847
-29
| -0.2% | -$2.26K | 0.77% | 42 |
|
|
2023
Q3 | $1.39M | Sell |
18,876
-801
| -4% | -$61.6K | 0.76% | 43 |
|
|
2023
Q2 | $1.52M | Buy |
19,677
+1
| +0% | +$80 | 0.78% | 37 |
|
|
2023
Q1 | $1.63M | Sell |
19,676
-250
| -1% | -$20.7K | 0.87% | 31 |
|
|
2022
Q4 | $1.71M | Hold |
19,926
| – | – | 0.89% | 33 |
|
|
2022
Q3 | $1.23M | Buy |
19,926
+2,531
| +15% | +$160K | 0.63% | 41 |
|
|
2022
Q2 | $1.07M | Sell |
17,395
-2,556
| -13% | -$158K | 0.56% | 52 |
|
|
2022
Q1 | $1.19M | Sell |
19,951
-516
| -3% | -$33K | 0.6% | 50 |
|
|
2021
Q4 | $1.49M | Sell |
20,467
-3,015
| -13% | -$208K | 0.71% | 35 |
|
|
2021
Q3 | $1.64M | Buy |
23,482
+4,125
| +21% | +$290K | 0.85% | 25 |
|
|
2021
Q2 | $1.33M | Buy |
19,357
+400
| +2% | +$26.7K | 0.72% | 37 |
|
|
2021
Q1 | $1.23M | Buy |
18,957
+50
| +0.3% | +$3.22K | 0.71% | 38 |
|
|
2020
Q4 | $1.1M | Sell |
18,907
-365
| -2% | -$22K | 0.74% | 34 |
|
|
2020
Q3 | $1.22M | Buy |
19,272
+860
| +5% | +$59.6K | 0.81% | 30 |
|
|
2020
Q2 | $1.42M | Sell |
18,412
-210
| -1% | -$16.1K | 0.99% | 24 |
|
|
2020
Q1 | $1.39M | Buy |
18,622
+6,155
| +49% | +$425K | 1.14% | 19 |
|
|
2019
Q4 | $810K | Sell |
12,467
-450
| -3% | -$29.3K | 0.49% | 52 |
|
|
2019
Q3 | $819K | Sell |
12,917
-25
| -0.2% | -$1.63K | 0.52% | 47 |
|
|
2019
Q2 | $874K | Buy |
12,942
+300
| +2% | +$19.7K | 0.59% | 42 |
|
|
2019
Q1 | $822K | Buy |
12,642
+565
| +5% | +$37.6K | 0.57% | 47 |
|
|
2018
Q4 | $755K | Hold |
12,077
| – | – | 0.62% | 44 |
|
|
2018
Q3 | $932K | Hold |
12,077
| – | – | 0.65% | 39 |
|
|
2018
Q2 | $856K | Buy |
12,077
+80
| +0.7% | +$5.65K | 0.63% | 44 |
|
|
2018
Q1 | $904K | Buy |
11,997
+1,000
| +9% | +$79.5K | 0.67% | 40 |
|
|
2017
Q4 | $788K | Buy |
10,997
+120
| +1% | +$9.11K | 0.56% | 47 |
|
|
2017
Q3 | $881K | Hold |
10,877
| – | – | 0.65% | 41 |
|
|
2017
Q2 | $770K | Buy |
10,877
+750
| +7% | +$49.9K | 0.53% | 44 |
|
|
2017
Q1 | $688K | Buy |
10,127
+1,330
| +15% | +$93.5K | 0.48% | 51 |
|
|
2016
Q4 | $630K | Buy |
8,797
+745
| +9% | +$55.4K | 0.47% | 55 |
|
|
2016
Q3 | $637K | Buy |
8,052
+907
| +13% | +$73.7K | 0.48% | 49 |
|
|
2016
Q2 | $596K | Buy |
7,145
+855
| +14% | +$75.9K | 0.46% | 48 |
|
|
2016
Q1 | $578K | Buy |
6,290
+110
| +2% | +$9.92K | 0.48% | 46 |
|
|
2015
Q4 | $625K | Buy |
6,180
+265
| +4% | +$27.6K | 0.52% | 46 |
|
|
2015
Q3 | $581K | Buy |
5,915
+125
| +2% | +$13.9K | 0.52% | 46 |
|
|
2015
Q2 | $678K | Hold |
5,790
| – | – | 0.58% | 43 |
|
|
2015
Q1 | $568K | Buy |
5,790
+150
| +3% | +$15.2K | 0.47% | 54 |
|
|
2014
Q4 | $532K | Buy |
+5,640
| New | +$583K | 0.46% | 58 |
|
Other funds holding GILD
Investors Asset Management of Georgia's GILD Position: Q2 2026 in Review
Investors Asset Management of Georgia increased its Gilead Sciences (GILD) stake by 0.02% in Q2 2026, buying an estimated $395 and bringing the position to 18,616 shares worth $2.35M. The position accounts for 0.82% of the portfolio, ranked #34.
Investors Asset Management of Georgia first reported a position in GILD in Q4 2014 and has held it in 47 quarters since. The position peaked at $2.59M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Investors Asset Management of Georgia held 18,616 shares of Gilead Sciences worth $2.35M as of Q2 2026.
- Investors Asset Management of Georgia bought 3 Gilead Sciences shares in Q2 2026, an estimated $395.
- Gilead Sciences made up 0.82% of Investors Asset Management of Georgia's portfolio in Q2 2026, its #34 holding.
- Investors Asset Management of Georgia first reported a position in Gilead Sciences in Q4 2014 and has held it in 47 quarters since.
- Investors Asset Management of Georgia's Gilead Sciences position peaked at $2.59M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Investors Asset Management of Georgia's 13F filing for Q2 2026, filed 22 Jul 2026.